Mukesh Kumar, MD
Hospitalist · Atlanta, GANPI 1659535086
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,112 of the $6,379 with a category attached, or 64.5%. Novartis accounts for 84.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $5,762 and has fallen 97.5% since, to $144 in 2025. Among hospitalist clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $375.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$5K
- E.r. Squibb & Sons, L.L.C.$566
- Edwards Lifesciences$144
- Gilead$106
- Novo Nordisk$104
- AstraZeneca$17
- plus $28 from 2 others
What the payments were for
- Consulting fees$4,11264%
- Travel & lodging$1,10617%
- Food & beverage$1,16218%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $5,416 |
| E.r. Squibb & Sons, L.L.C. | 5 | $566 |
| Edwards Lifesciences | 1 | $144 |
| Gilead | 1 | $106 |
| Novo Nordisk | 1 | $104 |
| AstraZeneca | 1 | $17 |
| Bayer | 1 | $15 |
| CTI Biopharma Corp. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTRESTO$5,353
- ELIQUIS$566
- SAPIEN 3 Ultra RESILIA$144
- Veklury$106
- Saxenda$104
How this compares
$6,379 in reported general payments places this provider in the 95th percentile of 812 hospitalist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydralazine Hcl | 12 | $152 |
| Pantoprazole Sodium | 19 | $126 |
| Carvedilol | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Atlanta
- Emilio LacayoAtlanta$9K
- Amaka EzimoraAtlanta$6K
- Pramod KakaralaAtlanta$5K
- Majid SheikhAtlanta$4K
- Richard RamonellAtlanta$4K
- Manpreet MalikAtlanta$4K
- Pranay PrabhakarAtlanta$4K
- Anup PatelAtlanta$3K
- Nnaemeka OkaroAtlanta$3K
- David WatsonAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.